FDA Proposes Rules For Listing Side Effects In Ads
In a noticed published in the Federal Register late last month, the FDA announced plans to set new standards for the clarity of drug ads as required by the Food and Drug Administration Amendments Act of 2007. The agency said it is soliciting comments on the proposal until June 28.
Under the 2007...
To view the full article, register now.